Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study
Clin Transl Sci, 2020.
Pan S, Tsakok T, Dand N, Lonsdale DO, Loeff FC, Bloem K, de Vries A, Baudry D, Duckworth M, Mahil S, Pushpaâ€Rajah A; Russell A, Alsharqi A, Becher G, Murphy R, Wahie S, Andrew Wright, Griffiths CEM, Reynolds NJ,Barker J, Warren RB, Burden AD, Theo Rispens , Joseph F Standing , Catherine H Smith; BADBIR Study Group; BSTOP Study Group; PSORT Consortium.
Read publication: Clin Transl Sci 2020
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-b...
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective c...
0 Comments